|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thorgeirsson SS and Grisham JW: Molecular
pathogenesis of human hepatocellular carcinoma. Nat Genet.
31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jung HI, Jeong D, Ji S, Ahn TS, Bae SH,
Chin S, Chung JC, Kim HC, Lee MS and Baek MJ: Overexpression of
PD-L1 and PD-L2 is associated with poor prognosis in patients with
hepatocellular carcinoma. Cancer Res Treat. 49:246–254. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gish RG, Porta C, Lazar L, Ruff P, Feld R,
Croitoru A, Feun L, Jeziorski K, Leighton J, Gallo J and Kennealey
GT: Phase III randomized controlled trial comparing the survival of
patients with unresectable hepatocellular carcinoma treated with
nolatrexed or doxorubicin. J Clin Oncol. 25:3069–3075. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Llovet JM, Brú C and Bruix J: Prognosis of
hepatocellular carcinoma: The BCLC staging classification. Seminars
Liver Disease. 19:329–338. 1999. View Article : Google Scholar
|
|
6
|
Yoo JJ, Chung GE, Lee JH, Nam JY, Chang Y,
Lee JM, Lee DH, Kim HY, Cho EJ, Yu SJ, et al: Sub-classification of
advanced-stage hepatocellular carcinoma: A cohort study including
612 patients treated with sorafenib. Cancer Res Treat. 50:366–373.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yoon KJ, Ringeling FR, Vissers C, Jacob F,
Pokrass M, Jimenez-Cyrus D, Su Y, Kim NS, Zhu Y, Zheng L, et al:
Temporal control of mammalian cortical neurogenesis by m(6)A
methylation. Cell. 171:877–889.e17. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schibler U, Kelley DE and Perry RP:
Comparison of methylated sequences in messenger RNA and
heterogeneous nuclear RNA from mouse L cells. J Mol Biol.
115:695–714. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wei CM and Moss B: Nucleotide sequences at
the N6-methyladenosine sites of HeLa cell messenger ribonucleic
acid. Biochemistry. 16:1672–1676. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Desrosiers R, Friderici K and Rottman F:
Identification of methylated nucleosides in messenger RNA from
Novikoff hepatoma cells. Proc Natl Acad Sci USA. 71:3971–3975.
1974. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei CM, Gershowitz A and Moss B:
Methylated nucleotides block 5′ terminus of HeLa cell messenger
RNA. Cell. 4:379–386. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao BS, Roundtree IA and He C:
Post-transcriptional gene regulation by mRNA modifications. Nat Rev
Mol Cell Biol. 18:31–42. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meyer KD, Saletore Y, Zumbo P, Elemento O,
Mason CE and Jaffrey SR: Comprehensive analysis of mRNA methylation
reveals enrichment in 3′ UTRs and near stop codons. Cell.
149:1635–1646. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Helm M and Motorin Y: Detecting RNA
modifications in the epitranscriptome: Predict and validate. Nat
Rev Genet. 18:275–291. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pinello N, Sun S and Wong JJ: Aberrant
expression of enzymes regulating m6A mRNA methylation: Implication
in cancer. Cancer Biol Med. 15:323–334. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Batista PJ: The RNA modification
N(6)-methyladenosine and its implications in human disease.
Genomics Proteomics Bioinformatics. 15:154–163. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou S, Bai ZL, Xia D, Zhao ZJ, Zhao R,
Wang YY and Zhe H: FTO regulates the chemo-radiotherapy resistance
of cervical squamous cell carcinoma (CSCC) by targeting β-catenin
through mRNA demethylation. Mol Carcinog. 57:590–597. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu ZX, Li LM, Sun HL and Liu SM: Link
between m6A modification and cancers. Front Bioeng Biotechnol.
6:892018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cai X, Wang X, Cao C, Gao Y, Zhang S, Yang
Z, Liu Y, Zhang X, Zhang W and Ye L: HBXIP-elevated
methyltransferase METTL3 promotes the progression of breast cancer
via inhibiting tumor suppressor let-7g. Cancer Lett. 415:11–19.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Taketo K, Konno M, Asai A, Koseki J,
Toratani M, Satoh T, Doki Y, Mori M, Ishii H and Ogawa K: The
epitranscriptome m6A writer METTL3 promotes chemo-and
radioresistance in pancreatic cancer cells. Int J Oncol.
52:621–629. 2018.PubMed/NCBI
|
|
21
|
Cheng X, Li M, Rao X, Zhang W, Li X, Wang
L and Huang G: KIAA1429 regulates the migration and invasion of
hepatocellular carcinoma by altering m6A modification of ID2 mRNA.
Onco Targets Ther. 12:3421–3428. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mayakonda A, Lin DC, Assenov Y, Plass C
and Koeffler HP: Maftools: Efficient and comprehensive analysis of
somatic variants in cancer. Genome Res. 28:1747–1756. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gevaert O: MethylMix: An R package for
identifying DNA methylation-driven genes. Bioinformatics.
31:1839–1841. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roessler S, Jia HL, Budhu A, Forgues M, Ye
QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX and Wang XW: A
unique metastasis gene signature enables prediction of tumor
relapse in early-stage hepatocellular carcinoma patients. Cancer
Res. 70:10202–10212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grinchuk OV, Yenamandra SP, Iyer R, Singh
M, Lee HK, Lim KH, Chow PK and Kuznetsov VA: Tumor-adjacent tissue
co-expression profile analysis reveals pro-oncogenic ribosomal gene
signature for prognosis of resectable hepatocellular carcinoma. Mol
Oncol. 12:89–113. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wilkerson D M, Hayes and Neil D:
ConsensusClusterPlus: a class discovery tool with confidence
assessments and item tracking. Bioinformatics. 26:1572–1573. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lacny S, Wilson T, Clement F, Roberts DJ,
Faris PD, Ghali WA and Marshall DA: Kaplan-Meier survival analysis
overestimates the risk of revision arthroplasty: A meta-analysis.
Clin Orthop Relat Res. 473:3431–3442. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tibshirani R: The lasso method for
variable selection in the Cox model. Stat Med. 16:385–395. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
American Joint Committee On Cancer, . AJCC
7th edition Cancer Staging Manual, 2009. https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC%207th%20Ed%20Cancer%20Staging%20Manual.pdfDecember
3–2019
|
|
30
|
Monti S, Tamayo P, Mesirov J and Golub T:
Consensus clustering: A resampling-based method for class discovery
and visualization of gene expression microarray data. Machine
Learn. 52:91–118. 2003. View Article : Google Scholar
|
|
31
|
Sun LY, Li XY and Sun ZW: Progress of
epigenetics and its therapeutic application in hepatocellular
carcinoma. Yi Chuan. 37:517–527. 2015.(In Chinese). PubMed/NCBI
|
|
32
|
Feo F, Frau M, Tomasi ML, Brozzetti S and
Pascale RM: Genetic and epigenetic control of molecular alterations
in hepatocellular carcinoma. Exp Biol Med (Maywood). 234:726–736.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Geula S, Moshitch-Moshkovitz S,
Dominissini D, Mansour AA, Kol N, Salmon-Divon M, Hershkovitz V,
Peer E, Mor N, Manor YS, et al: m6A mRNA methylation facilitates
resolution of naïve pluripotency toward differentiation. Science.
347:1002–1006. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lence T, Akhtar J, Bayer M, Schmid K,
Spindler L, Ho CH, Kreim N, Andrade-Navarro MA, Poeck B, Helm M and
Roignant JY: m6A modulates neuronal functions and sex
determination in Drosophila. Nature. 540:242–247. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Alarcón CR, Lee H, Goodarzi H, Halberg N
and Tavazoie SF: N 6-methyladenosine marks primary microRNAs for
processing. Nature. 519:482–485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He L, Li H, Wu A, Peng Y, Shu G and Yin G:
Functions of N6-methyladenosine and its role in cancer. Mol Cancer.
18:1762019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen Y, Peng C, Chen J, Chen D, Yang B, He
B, Hu W, Zhang Y, Liu H, Dai L, et al: WTAP facilitates progression
of hepatocellular carcinoma via m6A-HuR-dependent epigenetic
silencing of ETS1. Mol Cancer. 18:1272019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Meyer KD and Jaffrey SR: The dynamic
epitranscriptome: N6-methyladenosine and gene expression control.
Nat Rev Mol Cell Biol. 15:313–326. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shi H, Wei J and He C: Where, when, and
how: Context-dependent functions of RNA methylation writers,
readers, and erasers. Mol Cell. 74:640–650. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zaccara S, Ries RJ and Jaffrey SR:
Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell
Biol. 20:608–624. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang Y, Hsu PJ, Chen YS and Yang YG:
Dynamic transcriptomic m6A decoration: Writers, erasers,
readers and functions in RNA metabolism. Cell Res. 28:616–624.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang X, Li Z, Kong B, Song C, Cong J, Hou
J and Wang S: Reduced m6A mRNA methylation is correlated
with the progression of human cervical cancer. Oncotarget.
8:98918–98930. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kwok CT, Marshall AD, Rasko JE and Wong
JJ: Genetic alterations of m(6)A regulators predict poorer survival
in acute myeloid leukemia. J Hematol Oncol. 10:392017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cho SH, Ha M, Cho YH, Ryu JH, Yang K, Lee
KH, Han ME, Oh SO and Kim YH: ALKBH5 gene is a novel biomarker that
predicts the prognosis of pancreatic cancer: A retrospective
multicohort study. Ann Hepatobiliary Pancreat Surg. 22:305–309.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li Y, Xiao J, Bai J, Tian Y, Qu Y, Chen X,
Wang Q, Li X, Zhang Y and Xu J: Molecular characterization and
clinical relevance of m6A regulators across 33 cancer
types. Mol Cancer. 18:1372019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen SL, Liu LL, Wang CH, Lu SX, Yang X,
He YF, Zhang CZ and Yun JP: Loss of RDM1 enhances hepatocellular
carcinoma progression via p53 and Ras/Raf/ERK pathways. Mol Oncol.
14:373–386. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Huang H, Weng H, Sun W, Qin X, Shi H, Wu
H, Zhao BS, Mesquita A, Liu C, Yuan CL, et al: Recognition of RNA
N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and
translation. Nat Cell Biol. 20:285–295. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhao X, Chen Y, Mao Q, Jiang X, Jiang W,
Chen J, Xu W, Zhong L and Sun X: Overexpression of YTHDF1 is
associated with poor prognosis in patients with hepatocellular
carcinoma. Cancer Biomark. 21:859–868. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han
D, Fu Y, Parisien M, Dai Q, Jia G, et al:
N6-methyladenosine-dependent regulation of messenger RNA stability.
Nature. 505:117–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hou J, Zhang H, Liu J, Zhao Z, Wang J, Lu
Z, Hu B, Zhou J, Zhao Z, Feng M, et al: YTHDF2 reduction fuels
inflammation and vascular abnormalization in hepatocellular
carcinoma. Mol Cancer. 18:1632019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhong L, Liao D, Zhang M, Zeng C, Li X,
Zhang R, Ma H and Kang T: YTHDF2 suppresses cell proliferation and
growth via destabilizing the EGFR mRNA in hepatocellular carcinoma.
Cancer Lett. 442:252–261. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chen M, Wei L, Law CT, Tsang FH, Shen J,
Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, et al: RNA
N6-methyladenosine methyltransferase-like 3 promotes liver cancer
progression through YTHDF2-dependent posttranscriptional silencing
of SOCS2. Hepatology. 67:2254–2270. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhou B, Liu C, Xu L, Yuan Y, Zhao J, Zhao
W, Chen Y, Qiu J, Meng M, Zheng Y, et al:
N6-methyladenosine reader protein Ythdc2 suppresses
liver steatosis via regulation of mRNA stability of lipogenic
genes. Hepatology. Mar 9–2020.(Epub ahead of print). doi:
10.1002/hep.31220.
|
|
54
|
Han D, Liu J, Chen C, Dong L, Liu Y, Chang
R, Huang X, Liu Y, Wang J, Dougherty U, et al: Anti-tumour immunity
controlled through mRNA m(6)A methylation and YTHDF1 in dendritic
cells. Nature. 566:270–274. 2019. View Article : Google Scholar : PubMed/NCBI
|
